Thu.Jan 02, 2025

article thumbnail

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

The Pharmacist

More than 50 pharmacies have closed in the last three years despite being given despite special protection funding from the government under the Pharmacy Access Scheme. This represents 4% of the 1,444 pharmacies eligible to claim funding under the scheme set up to 'capture the pharmacies that are most important for patient access, those […] The post More than 50 Access Scheme pharmacies have closed since 2022, NPA claims appeared first on The Pharmacist.

134
134
article thumbnail

4 companies to watch in the accelerating gene editing race

PharmaVoice

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

321
321
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Type 1 diabetes market to reach $9.9 bn in 7MM by 2033

Express Pharma

The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 billion in 2033, driven by the anticipated introduction of several late-stage pipeline products, including multiple immunomodulatory agents, during the forecast period, according to GlobalData.

Diabetes 105
article thumbnail

Morrisons launches online private prescription service with Phlo

The Pharmacist

Supermarket Morrisons has today launched an online private prescription service, called Morrisons Clinic. The clinic has been launched in partnership with digital pharmacy Phlo. It offers a range of services including treatment for acid reflux, acne, erectile dysfunction, menopause, and contraceptive and weight loss services. In a statement released today, Morrisons said that customers in […] The post Morrisons launches online private prescription service with Phlo appeared first on The Ph

124
124
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

UK regulator warns against buying weight-loss medicines without prescription

Pharma Times

MHRA urges caution over illegal medicines from beauty salons and social media

146
146

More Trending

article thumbnail

EC approves Rybrevant with Lazcluze for advanced lung cancer

Pharma Times

New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC

article thumbnail

Triumphing in trials

pharmaphorum

The challenges facing oncology clinical trials are multifaceted, but there is a clear opportunity for pharmaceutical companies to rethink their approach to clinical research, and prioritise the patient from the beginning.

article thumbnail

Tirzepatide outpacing Wegovy in the obesity space

Pharmaceutical Technology

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.

109
109
article thumbnail

Early cancer diagnoses reach record level in NHS

pharmaphorum

Early cancer diagnoses have risen to record levels in England, says NHS, but long waiting times for treatment threaten to undermine the gains.

111
111
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

10 clinical trials to watch in the first half of 2025

BioPharma Dive

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology sector regain its footing after a shaky year.

Diabetes 109
article thumbnail

Roche licenses Innovent ADC that could challenge Amgen drug

pharmaphorum

Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market

105
105
article thumbnail

CRIUS Lifesciences integrates NutrifyGenie AI in its project execution

Express Pharma

CRIUS Lifesciences has integrated artificial intelligence (AI) into its project execution processes. By integrating the NutrifyGenie AI platform, CRIUS aims to encourage innovation, efficiency and faster production cycles. NutrifyGenie AI has facilitated the end-to-end execution of a project. The technology automates ideation, product design, sourcing, and regulatory navigation.

98
article thumbnail

Flagship-backed AI startup Valo shelves eye disease drug

pharmaphorum

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug

Diabetes 105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Cancer-preventing topical immunotherapy trains the immune system to fight precancers

World Pharma News

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments.

article thumbnail

Neumora laid low by depression trial failure

pharmaphorum

The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price

104
104
article thumbnail

Neumora plummets on depression drug data

BioPharma Dive

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results as a “worst-case scenario for the program.

70
article thumbnail

Hutchmed cashes in a Chinese JV to help fund its pipeline

pharmaphorum

Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

FDA Publishes Final Guidance on Advanced Manufacturing Technologies

PharmaTech

The guidance provides recommendations for those interested in participating in FDAs Advanced Manufacturing Technologies Designation Program.

69
article thumbnail

Artificial intelligence and atopic dermatitis: A new era for disease management?

Pharmaceutical Technology

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.

64
article thumbnail

Astellas Pharma Recalls PROGRAF and ASTAGRAF XL Capsules

PharmaTech

The company is recalling one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules because some bottles may contain empty capsules.

64
article thumbnail

FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024

BioPharma Dive

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.

64
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Leading strategic intelligence solutions for the pharmaceteutical industry

Pharmaceutical Technology

Explore how strategic intelligence agencies and competitive intelligence solutions are shaping the pharmaceutical industry. Download our guide to technological advancements and more invaluable industry insights.

59
article thumbnail

Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals

BioPharma Dive

Sangamo shares fell on Pfizer’s decision to hand back rights to a hemophilia gene therapy. Elsewhere, Novartis got long-awaited data and BioNTech settled with the NIH.

60
article thumbnail

Neumora shares sink following Phase III flop in MDD

Pharmaceutical Technology

The Phase III KOASTAL-1 study with Neumoras lead asset navacaprant failed to meet its primary and secondary endpoint.

59
article thumbnail

Brii Biosciences acquires BRII-179 assets from VBI Vaccines

Pharmaceutical Business Review

This strategic move involves a total payment of $18m and terminates prior agreements with VBI, including future milestone and royalty obligations. Under the terms of the agreement, Brii Bio is set to obtain complete ownership of the therapys patents, materials, and know-how. The transaction also cancels all payment obligations from Brii, except for an outstanding $2.5m promissory note, following the dissolution of VBI’s operations.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.